GP-Act III Acquisition Corp. 8-K

What Happened

• On March 30, 2026, GP-Act III Acquisition Corp. filed a definitive Proxy Statement (Schedule 14A) to call an Extraordinary General Meeting (record date March 24, 2026) asking shareholders to approve amendments to (1) its Articles and (2) the Investment Management Trust Agreement (IMTA) to extend the deadline to complete a business combination and the trustee liquidation date from May 13, 2026 to November 13, 2026.
• The company and GP-Act III Sponsor LLC expect to enter into non‑redemption agreements with some public shareholders under which those shareholders agree not to redeem specified Class A ordinary shares and to vote in favor of the extension; in return Sponsor HoldCo anticipates transferring a negotiated number of Class A shares to those shareholders after a business combination closes.

Key Details

• Proxy filed: March 30, 2026; record date for the meeting: March 24, 2026; proxy materials mailed beginning ~March 30, 2026.
• Proposed extension: from May 13, 2026 to November 13, 2026 (both Articles and IMTA/trust liquidation).
• Trustee under IMTA: Continental Stock Transfer & Trust Company (IMTA dated May 8, 2024).
• Non‑Redemption Agreements: terminate on earliest of several events (including failure to approve extension, fulfillment of obligations, liquidation/dissolution, mutual written agreement, or if a shareholder redeems or fails to vote in favor). Sponsor may transfer Class A shares to participants post-closing.

Why It Matters

• If approved, the extension gives the SPAC six more months to complete a merger or other business combination, which may increase chances of closing a deal.
• Non‑redemption agreements are intended to reduce redemptions at the vote and keep more money in the trust account, preserving funds available for a potential transaction; they may, however, affect post‑closing share distribution (Sponsor share transfers).
• Shareholders should read the definitive proxy and related filings (available free at sec.gov or via the proxy solicitor Sodali & Co. at [email protected]) before voting; the filing also includes standard forward‑looking disclaimers and references to risk factors.